BioCentury | Jan 2, 2012
Finance

Living creatively

...markets: Bergamo by Amgen Inc. (NASDAQ:AMGN); Corporacion Infarmasa S.A. by Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA); Dr. F. Frik Ilac...
BioCentury | Sep 26, 2011
Company News

Recordati, Dr. F. Frik Ilac A.S. deal

...acquisition of Dr. F. Frik Ilac for $130 million (see BioCentury, July 11). Recordati S.p.A. (Milan:REC), Milan, Italy Dr. F. Frik Ilac...
BioCentury | Jul 11, 2011
Company News

Recordati, Dr. F. Frik Ilac A.S. deal

...Recordati will acquire pharmaceutical company Dr. F. Frik Ilac for about $130 million in cash. Dr. F. Frik Ilac provides prescription products...
...months. Dr. F. Frik Ilac reported 2010 sales of €44 million ($63.9 million). Recordati S.p.A. (Milan:REC), Milan, Italy Dr. F. Frik Ilac...
Items per page:
1 - 3 of 3
BioCentury | Jan 2, 2012
Finance

Living creatively

...markets: Bergamo by Amgen Inc. (NASDAQ:AMGN); Corporacion Infarmasa S.A. by Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA); Dr. F. Frik Ilac...
BioCentury | Sep 26, 2011
Company News

Recordati, Dr. F. Frik Ilac A.S. deal

...acquisition of Dr. F. Frik Ilac for $130 million (see BioCentury, July 11). Recordati S.p.A. (Milan:REC), Milan, Italy Dr. F. Frik Ilac...
BioCentury | Jul 11, 2011
Company News

Recordati, Dr. F. Frik Ilac A.S. deal

...Recordati will acquire pharmaceutical company Dr. F. Frik Ilac for about $130 million in cash. Dr. F. Frik Ilac provides prescription products...
...months. Dr. F. Frik Ilac reported 2010 sales of €44 million ($63.9 million). Recordati S.p.A. (Milan:REC), Milan, Italy Dr. F. Frik Ilac...
Items per page:
1 - 3 of 3